Publications

The FDA’s new guidance on payer communications: Implications for real-world data and value-based contracts

Published on July 17, 2018 Citation: Neumann PJ, Weissman H. "The FDA’s New Guidance On Payer Communications: Implications For Real-World Data And Value-Based Contracts," Health Affairs Blog, July 17, 2018. Journal: Health Affairs Blog Read Publication

Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: Trends in cost-per-DALY studies

Published on July 16, 2018 Citation: Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value in Health 2018;21(7):759–61. Journal: Value Health Read Publication

Specialty Drug Coverage Varies Across Commercial Health Plans In The US

Published on July 9, 2018 Citation: Chambers JD, Kim DD, Pope EF, Graff JS, Wilkinson CL, Neumann PJ. Specialty Drug Coverage Varies Across Commercial Health Plans In The US. Health Affairs 2018;37(7):1041–7. Journal: Health Affairs Read Publication

Hemophilia burden of disease: A systematic review of the cost-utility literature for hemophilia

Published on July 1, 2018 Citation: Thorat T, Neumann PJ, Chambers JD. Hemophilia burden of disease: A systematic review of the cost-utility literature for hemophilia. Journal of Managed Care & Specialty Pharmacy 2018;24(7):632–42. Journal: Journal of Managed Care & Specialty Pharmacy Read Publication

QALYs in 2018—Advantages and Concerns

Published on June 26, 2018 Citation: Neumann PJ, Cohen JT. QALYs in 2018—Advantages and Concerns. Jama 2018;319(24):2473. Journal: JAMA Read Publication

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

Published on June 14, 2018 Citation: Goldman DP, Fillit H, Neumann P. Accelerating Alzheimers disease drug innovations from the research pipeline to patients. Alzheimers & Dementia 2018; Journal: Alzheimers & Dementia Read Publication

Excluding patients from transplant due to social support: Results from a national survey of transplant providers

Published on June 7, 2018 Citation: Ladin K, Emerson J, Berry K, Butt Z, Gordon EJ, Daniels N, Lavelle TA, Hanto DW. Excluding patients from transplant due to social support: Results from a national survey of transplant providers. American Journal of Transplantation 2018; Journal: American Journal of Transplantation Read Publication

Economic value of greater access to bariatric procedures for patients with severe obesity and diabetes

Published on May 12, 2018 Citation: Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Medical Care 2018;:1. Journal: Medical Care Read Publication

A comparison of coverage restrictions for biopharmaceuticals and medical procedures

Published on May 1, 2018 Citation: Chambers J, Pope E, Bungay K, Cohen JT, Ciarametaro M, Dubois R, Neumann PJ. A comparison of coverage restrictions for biopharmaceuticals and medical procedures. Value in Health 2018;21(4):400–6. Journal: Value in Health Read Publication

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes

Published on April 29, 2018 Citation: Parsons SK, Kelly MJ, Cohen JT, Castellino SM, Henderson T, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM. Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. Br J Haematol. 2018 Apr 29. doi: 10.1111/bjh.15255. Journal: British Journal of Haematolgy Read Publication